Inovio Pharmaceuticals, Inc. (INO)
1.15
+0.02
(+1.77%)
USD |
NASDAQ |
Oct 07, 16:00
1.17
+0.02
(+1.74%)
After-Hours: 20:00
Inovio Pharmaceuticals Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2025 | -30.16K% |
| December 31, 2024 | -16.57K% |
| September 30, 2024 | |
| June 30, 2024 | -31.98K% |
| March 31, 2024 | |
| December 31, 2023 | -24.35K% |
| September 30, 2023 | -8.74K% |
| June 30, 2023 | -15.72K% |
| March 31, 2023 | -35.38K% |
| December 31, 2022 | -43.68K% |
| September 30, 2022 | -412.8% |
| June 30, 2022 | -13.83K% |
| March 31, 2022 | -39.72K% |
| December 31, 2021 | -12.75K% |
| September 30, 2021 | -20.63K% |
| June 30, 2021 | -30.11K% |
| March 31, 2021 | -14.66K% |
| December 31, 2020 | -436.1% |
| September 30, 2020 | |
| June 30, 2020 | -48.34K% |
| March 31, 2020 | -2.50K% |
| December 31, 2019 | -13.65K% |
| September 30, 2019 | -2.72K% |
| June 30, 2019 | -21.80K% |
| March 31, 2019 | -1.03K% |
| Date | Value |
|---|---|
| December 31, 2018 | -1.32K% |
| September 30, 2018 | -1.25K% |
| June 30, 2018 | -27.16% |
| March 31, 2018 | -2.11K% |
| December 31, 2017 | -244.7% |
| September 30, 2017 | -1.29K% |
| June 30, 2017 | -46.44% |
| March 31, 2017 | -222.5% |
| December 31, 2016 | -308.1% |
| September 30, 2016 | -165.5% |
| June 30, 2016 | -301.5% |
| March 31, 2016 | -99.17% |
| December 31, 2015 | -302.4% |
| September 30, 2015 | 23.13% |
| June 30, 2015 | -116.6% |
| March 31, 2015 | -204.8% |
| December 31, 2014 | -301.7% |
| September 30, 2014 | -584.9% |
| June 30, 2014 | -330.3% |
| March 31, 2014 | -459.4% |
| December 31, 2013 | -889.1% |
| September 30, 2013 | -325.6% |
| June 30, 2013 | -1.38K% |
| March 31, 2013 | -608.7% |
| December 31, 2012 | -59.16% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Nektar Therapeutics | -401.0% |
| Ironwood Pharmaceuticals, Inc. | 45.37% |
| Fortress Biotech, Inc. | 3.22% |
| Tonix Pharmaceuticals Holding Corp. | -299.4% |
| Kura Oncology, Inc. | -327.3% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -609.1% |
| Return on Assets | -107.9% |
| Return on Invested Capital | -330.2% |
| Return on Net Operating Assets | -541.8% |